Dr. Abud Bakri

The most commercially available is going to be a lymphocyte count, which is like a CD4 to CD8.

There's an ideal CD4 to CD8 ratio that's more youthful.

You don't want to have more CD8 cells than CD4 cells.

You don't want to have too few of either of them.

That goes more into like the HIV literature.

But the most simple thing that almost every single person has gotten done but no one's looked at is their lymphocyte to monocyte ratio on their CBC.

So almost everybody's gotten a CBC with DIF.

It's a $3 lab test.

If you type in any disorder, cardiovascular disease, cancer, diabetes, and put lymphocyte to monocyte ratio, there's a study that will talk about how a low lymphocyte to monocyte ratio is associated with poor outcomes when it comes to that disease state.

Hmm.

So it gives you kind of a general gestalt of what's going on with the immunity, because you want a high absolute lymphocyte count, not too high, because it's associated with like lymphomas, but somewhere the hazard, when you look at the charts, around 1,000 total lymphocytes is where the hazard of different cancer starts to increase.

a young healthy person will be between 1,500 and 33,000 total lymphocytes.

And you want the ratio to the monocytes.

Monocytes are different types of immune cells that are more inflammatory.

So if you have a robust amount of lymphocytes with low amount of monocytes, that suggests you have a more, let's say, ready and robust immune state.

So $3 lab test that everybody gets, almost every lab testing company now checks it and no one really reports on it.

But you can kind of stratify people into disease risk based on that score.

Why not?

It's like rabbit holes that you kind of go down and find out.

Like I've been lobbying everyone in the hospital to look at this.